{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:05:00Z","timestamp":1784192700120,"version":"3.55.0"},"reference-count":63,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Canine mammary tumors have been investigated to determine the causes of malignancy and to promote the development of more effective therapies. The current standard of care, surgical resection where possible, often still results in recurrence of disease. Thus, there is an unmet need for better, more effective therapies that can suppress recurrence in canine patients. Because canine and human mammary cancers, particularly carcinomas and adenocarcinomas, share many similarities in genetic defects, etiology, natural history, and environment, canine mammary cancer cell lines have also been used as effective models of human disease. The genetics and immune response to canine mammary\/breast cancers have been investigated to better understand this disease complex and to promote the development of more effective therapies designed to treat individual canine patients. As cancer is a heterogeneous disease, the potential to determine and possibly predict the mechanisms promoting neoplasia would allow the advancement of targeted therapeutic targets\/strategies to combat cancer directly. These investigations have led to the development and evaluation of immunotherapies designed to elicit immune recognition of cancer and its suppression, thus improving survival. Hybrid dendritic-cell fusion vaccines and other autologous cancer vaccine formulations have proven effective in suppressing recurrence and extending survival in canine mammary cancer patients following surgical resection. Although current vaccines are somewhat impractical for direct application in veterinary clinics, reported success points the way toward the development of more practical vaccines designed to promote the treatment of canine mammary cancer. They also suggest a possible mechanism whereby removing a tumor from its microenvironment can promote antigenicity by removing local extracellular vesicle-mediated immunosuppression. This review provides a novel perspective on the potential of canine genetics to inform and promote more successful immunotherapies and their value as models of human disease.<\/jats:p>","DOI":"10.3390\/genes17070794","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:51:09Z","timestamp":1783936269000},"page":"794","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of Autologous Dendritic Cell Vaccine Therapeutics for Canine Mammary Cancer"],"prefix":"10.3390","volume":"17","author":[{"given":"Richard Curtis","family":"Bird","sequence":"first","affiliation":[{"name":"Department of Pathobiology, College of Veterinary Medicine, Scott-Ritchey Research Center, Auburn University Research Initiative in Cancer (AURIC), Auburn University, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2460\/ajvr.1996.57.05.693","article-title":"Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines","volume":"57","author":"Ahern","year":"1996","journal-title":"Am. J. Vet. Res."},{"key":"ref_2","unstructured":"Baba, A.I., and C\u00e2toi, C. (2007). Mammary Gland Tumors. Comparative Oncology, The Publishing House of the Romanian Academy. Chapter 11."},{"key":"ref_3","unstructured":"Vail, D.M., Thamm, D.H., and Liptak, J.M. (2020). Withrow and MacEwen\u2019s Small Animal Clinical Oncology, Elsevier Inc. Saunders. [6th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100612","DOI":"10.1016\/j.tvjl.2026.106612","article-title":"Descriptive epidemiology of canine and feline cancer in California, United States from 2000 to 2019","volume":"317","author":"Rupasinghe","year":"2026","journal-title":"Vet. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/vco.12839","article-title":"Lifetime prevalence of malignant and benign tumours in companion dogs: Cross-sectional analysis of Dog Aging Project baseline survey","volume":"20","author":"Schwartz","year":"2022","journal-title":"Vet. Comp. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nosalova, N., Huniadi, M., Hor\u0148\u00e1kov\u00e1, L., Valen\u010d\u00e1kov\u00e1, A., Hor\u0148\u00e1k, S., Nagoos, K., Vozar, J., and Cizkova, D. (2024). Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052891"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.15386\/mpr-2733","article-title":"Exploring the contrasts: In-depth analysis of human and canine mammary tumors\u2014Discoveries at the frontier","volume":"97","author":"Tomuleasa","year":"2024","journal-title":"Med. Pharm. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Carvalho, P.T., Niza-Ribeiro, J., Amorim, I., Queiroga, F., Severo, M., Ribeiro, A.I., and Pinello, K. (2023). Comparative Epidemiological Study of Breast Cancer in Humans and Canine Mammary Tumors: Insights From Portugal. Front. Vet. Sci., 10.","DOI":"10.3389\/fvets.2023.1271097"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"941275","DOI":"10.1155\/2013\/941275","article-title":"Breed Predispositions to Cancer in Pedigree Dogs","volume":"2013","author":"Dobson","year":"2013","journal-title":"ISRN Vet. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3233\/BD-2007-28102","article-title":"Comparative Pathology of Mammary Gland Cancers in Domestic and Wild Animals","volume":"28","author":"Munson","year":"2007","journal-title":"Breast. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Vazquez, E., Lipovka, Y., Cervantes-Arias, A., Garibay-Escobar, A., Haby, M.M., Queiroga, F.L., and Velazquez, C. (2023). Canine Mammary Cancer: State of the Art and Future Perspectives. Animals, 13.","DOI":"10.3390\/ani13193147"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4142\/jvs.2017.18.2.149","article-title":"Estrogen Receptor-\u03b1, Progesterone Receptor and c-erbB\/HER-Family Receptor mRNA Detection and Phenotype Analysis in Spontaneous Canine Models of Breast Cancer","volume":"18","author":"DeInnocentes","year":"2017","journal-title":"J. Vet. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"dmm040444","DOI":"10.1242\/dmm.040444","article-title":"Next-generation RNA sequencing of FFPE subsections reveals highly conserved stromal reprogramming between canine and human mammary carcinoma","volume":"12","author":"Amini","year":"2019","journal-title":"Dis. Models Mech."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcpa.2012.08.009","article-title":"Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers","volume":"148","author":"Kim","year":"2013","journal-title":"J. Comp. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1007\/s13277-015-3661-2","article-title":"Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: Is the dog a suitable animal model for human breast cancer?","volume":"36","author":"Burrai","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.pmbts.2021.12.003","article-title":"Canine Models of Human Cancer: Bridging the Gap to Improve Precision Medicine","volume":"189","author":"Nance","year":"2022","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jnci\/77.3.783","article-title":"Biologic properties of cell lines derived from canine mammary carcinomas","volume":"77","author":"Wolfe","year":"1986","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bird, R.C., and Smith, B.F. (2025). Comparative Genetics of Canine and Human Cancers. Vet. Sci., 12.","DOI":"10.3390\/vetsci12090875"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/jcb.25243","article-title":"Altered miRNA Expression Profiles Identify miR-141 as the Regulator of INK4A (p16 and p14ARF) Tumor Suppressor Genes in Canine Breast Cancer Models","volume":"116","author":"DeInnocentes","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2273","article-title":"Translation of New Cancer Treatments from Pet Dogs to Humans","volume":"8","author":"Paoloni","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1101\/gr.3736605","article-title":"The canine genome","volume":"15","author":"Ostrander","year":"2005","journal-title":"Genome Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tree.2006.08.001","article-title":"Genomics and conservation genetics","volume":"21","author":"Kohn","year":"2006","journal-title":"Trends Ecol. Evol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13059-023-03023-7","article-title":"Genome sequencing of 2000 canids by the Dog10K consortium advances the understanding of demography, genome function and architecture","volume":"24","author":"Meadows","year":"2023","journal-title":"Genome Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"106055","DOI":"10.1016\/j.tvjl.2023.106055","article-title":"Profiling canine mammary tumors: A potential model for studying human breast cancer","volume":"303","author":"Gherman","year":"2024","journal-title":"Vet. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/vco.12996","article-title":"Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer","volume":"22","author":"Guerreiro","year":"2024","journal-title":"Vet. Comp. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jcb.24300","article-title":"Novel frameshift mutation in the p16\/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16\/INK4A\/p14ARF locus","volume":"114","author":"Agarwal","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11626-021-00571-9","article-title":"Frequent genetic defects in the p16\/INK4A tumor suppressor in canine cell models of breast cancer and melanoma","volume":"57","author":"DeInnocentes","year":"2021","journal-title":"In Vitro Cell. Dev. Biol.-Anim."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jcb.22034","article-title":"Phenotype-rescue of cyclin-dependent kinase inhibitor p16\/INK4A defects in a spontaneous canine cell model of breast cancer","volume":"106","author":"DeInnocentes","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"ref_29","unstructured":"Yoshida, K. (2009). Defects in Genes Regulating the Cell Cycle in Spontaneous Canine Models of Cancer. Trends in Cell Cycle Research, Research Sign Post."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lutful Kabir, F.M., Alvarez, C.E., and Bird, R.C. (2015). Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression. Vet. Sci., 3.","DOI":"10.3390\/vetsci3010001"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1186\/1471-2407-10-618","article-title":"Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles","volume":"10","author":"Klopfleisch","year":"2010","journal-title":"BMC Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10617","DOI":"10.1007\/s11033-023-08863-x","article-title":"Research progress of good markers for canine mammary carcinoma","volume":"50","author":"Yang","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1186\/s12885-024-13239-w","article-title":"Differential somatic coding variant landscapes between laser microdissected luminal epithelial cells from canine mammary invasive ductal solid carcinoma and comedocarcinoma","volume":"24","author":"Deckwirth","year":"2024","journal-title":"BMC Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1476-5829.2006.00105.x","article-title":"Expression and sequence of canine SIRT2 and p53 genes in canine mammary tumour cells\u2014Effects on downstream targets Wip1 and p21\/Cip1","volume":"4","author":"DeInnocentes","year":"2006","journal-title":"Vet. Comp. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12272-024-01524-y","article-title":"Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: Similarities, opportunities, and challenges","volume":"48","author":"Bhutta","year":"2025","journal-title":"Arch. Pharm. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ccell.2026.03.009","article-title":"Reactivating p53 mutants selectively in patients","volume":"44","author":"Chen","year":"2026","journal-title":"Cancer Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41586-025-10004-2","article-title":"Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC","volume":"651","author":"Sahin","year":"2026","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101913","DOI":"10.1016\/j.gendis.2025.101913","article-title":"Dendritic cell vaccines: Current research progress, challenges, and opportunities","volume":"13","author":"Zhang","year":"2026","journal-title":"Genes Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-2427(90)90092-7","article-title":"Immunological aspects of mammary tumors in dogs and cats: A survey including own studies and pertinent literature","volume":"26","author":"Rutten","year":"1990","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cell.2006.05.051","article-title":"Clonal origin and evolution of a transmissible cancer","volume":"126","author":"Murgia","year":"2006","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.176.3.1447","article-title":"Tumor-specific CD4\u2212 T Cells Are Activated by \u201cCross-Dressed\u201d dendritic cells presenting peptide-MHC Class II complexes acquired from cell-based cancer vaccines","volume":"176","author":"Dolan","year":"2006","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02623551","article-title":"A macrophage-monocyte cell line from a dog with malignant histiocytosis","volume":"24","author":"Wellman","year":"1988","journal-title":"In Vitro Cell. Dev. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.vetimm.2008.02.013","article-title":"An allogeneic hybrid-cell fusion vaccine against canine mammary cancer","volume":"123","author":"Bird","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00262-010-0921-2","article-title":"An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine","volume":"60","author":"Bird","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.4142\/jvs.2019.20.e48","article-title":"Autologous Hybrid Cell Fusion Vaccine in a Spontaneous Intermediate Model of Breast Carcinoma","volume":"20","author":"Bird","year":"2019","journal-title":"J. Vet. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"114685","DOI":"10.1016\/j.biopha.2023.114685","article-title":"Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy","volume":"162","author":"Qian","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Srisawat, W., Koonyosying, P., Muenthaisong, A., Sangkakam, K., Varinrak, T., and Sthitmatee, N. (2025). Preliminary Exploration of MAGE-B1, -B4, -B5, and -B10 mRNA Expression in Canine Mammary Tumors in Dogs. Animals, 15.","DOI":"10.3390\/ani15070910"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/978-0-387-69080-3_60","article-title":"Gonadotrophin releasing hormone-based vaccine, an effective candidate for prostate cancer and other hormone-sensitive neoplasms","volume":"617","author":"Junco","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e004044","DOI":"10.1136\/jitc-2021-004044","article-title":"Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer","volume":"10","author":"Valdivia","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1186\/s12885-018-4750-6","article-title":"Malignant Canine Mammary Epithelial Cells Shed Exosomes Containing Differentially Expressed MicroRNA That Regulate Oncogenic Networks","volume":"18","author":"Fish","year":"2018","journal-title":"BMC Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/jvim.15764","article-title":"Circulating MicroRNA as Biomarkers of Canine Mammary Carcinoma","volume":"34","author":"Fish","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Markkanen, E. (2019). Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human MammaryTumors. Front. Cell Dev. Biol., 7.","DOI":"10.3389\/fcell.2019.00348"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ccell.2026.03.002","article-title":"Immunometabolic gatekeeping: How tissue metabolism conditions tumor immunity","volume":"44","author":"Elphick","year":"2026","journal-title":"Cancer Cell"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Higgins, T.A., Patton, D.J., Shimko-Lofano, I.M., Eller, T.L., Molinari, R., Sandey, M., Ismail, A., Smith, B.F., and Agarwal, P. (2024). The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment In Vitro. Cells, 13.","DOI":"10.3390\/cells13040351"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Mei, C., Liu, Y., Liu, Z., Zhi, Y., Jian, Z., Lyu, X., and Wang, H. (2024). Dysregulated Signaling Pathways in Canine Mammary Tumor and Human Triple Negative Breast Cancer: Advances and Potential Therapeutic Targets. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26010145"},{"key":"ref_56","unstructured":"Martinez-Romero, G., DeInnocentes, P., Koehler, J.W., Moss, A.G., Judd, R.L., and Bird, R.C. (Mammaglobin-A mRNA and Protein Expression Profiles in Canine Mammary Cancer Cell Lines and Tissues, 2026). Mammaglobin-A mRNA and Protein Expression Profiles in Canine Mammary Cancer Cell Lines and Tissues, manuscript in preparation."},{"key":"ref_57","unstructured":"Martinez-Romero, G., DeInnocentes, P., Koehler, J.W., Moss, A.G., Judd, R.L., and Bird, R.C. (Evaluation of Autologous Mammaglobin-A Loaded Dendritic Cells as a Potent Cancer Immunotherapy, 2026). Evaluation of Autologous Mammaglobin-A Loaded Dendritic Cells as a Potent Cancer Immunotherapy, manuscript in preparation."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"106370","DOI":"10.1016\/j.intimp.2020.106370","article-title":"IL-18 immunoadjuvanted xenogeneic canine MMP-7 DNA vaccine overcomes immune tolerance and supresses the growth of murine mammary tumor","volume":"82","author":"Yadav","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Lucroy, M.D., Clauson, R.M., Suckow, M.A., El-Tayyeb, F., and Kalinauskas, A. (2020). Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: A preliminary study. BMC Vet. Res., 16.","DOI":"10.1186\/s12917-020-02675-y"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1098612X211031504","article-title":"Field safety experience with an autologous cancer vaccine in tumor-bearing cats: A retrospective study of 117 cases (2015\u20132020)","volume":"24","author":"Lucroy","year":"2022","journal-title":"J. Feline Med. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"103948","DOI":"10.1016\/j.jevs.2022.103948","article-title":"Field Safety Experience With an Autologous Cancer Vaccine in 41 Horses: A Retrospective Study (2019\u20132021)","volume":"114","author":"Chelsea","year":"2022","journal-title":"J. Equine Vet. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.21873\/anticanres.16168","article-title":"Use of Conditioned Extracellular Matrix as a Tissue-engineered Tumor Matrisome for Prostate Cancer and Melanoma Immunotherapy","volume":"43","author":"Suckow","year":"2023","journal-title":"Anticancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41586-026-10353-6","article-title":"mRNA vaccines engage unconventional pathways in CD8+ T cell priming","volume":"654","author":"Jo","year":"2026","journal-title":"Nature"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/7\/794\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:28:41Z","timestamp":1784190521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/7\/794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["genes17070794"],"URL":"https:\/\/doi.org\/10.3390\/genes17070794","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,12]]}}}